Insider Move: Michael Kirshbaum Sold 2,400 Shares of The Advisory Board Company (NASDAQ:ABCO)

November 23, 2016 - By Vivian Park

Insider Move: Michael Kirshbaum Sold 2,400 Shares of The Advisory Board Company (NASDAQ:ABCO)

Michael Kirshbaum Insider Sell

Michael Kirshbaum; that is an insider in Advisory Board Co who is the most recent to sell shares in the corporation for which he is at present the Chief Financial Officer. He in the last few days unloaded some 2,400 shares of the company, valued by the stock market at $86,520 USD, that is a share price of precisely $36.1. Michael is trying to quietly decrease his company’s share, same as he did in the last month. He sold another 2,400 shares worth $102,720 USD. Michael Kirshbaum owns 0.11% of the -company’s market cap or 43,103 shares.

The Advisory Board Company (NASDAQ:ABCO) Ratings Coverage

Out of 14 analysts covering Advisory Board (NASDAQ:ABCO), 9 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 64% are positive. $65 is the highest target while $40 is the lowest. The $53.60 average target is 45.45% above today’s ($36.85) stock price. Advisory Board has been the topic of 19 analyst reports since August 5, 2015 according to StockzIntelligence Inc. The stock of The Advisory Board Company (NASDAQ:ABCO) has “Sector Weight” rating given on Monday, April 18 by KeyBanc Capital Markets. BMO Capital Markets upgraded the stock to “Market Perform” rating in Monday, August 31 report. The firm earned “Overweight” rating on Friday, September 30 by Barclays Capital. The rating was upgraded by Robert W. Baird on Monday, August 17 to “Outperform”. The stock of The Advisory Board Company (NASDAQ:ABCO) earned “Strong-Buy” rating by Zacks on Friday, August 7. As per Monday, November 7, the company rating was downgraded by Bank of America. The firm has “Overweight” rating by Barclays Capital given on Wednesday, August 5. JP Morgan initiated The Advisory Board Company (NASDAQ:ABCO) on Tuesday, November 17 with “Overweight” rating. The firm has “Buy” rating given on Tuesday, November 10 by Cantor Fitzgerald. The company was maintained on Wednesday, August 5 by Oppenheimer.

Insitutional Activity: The institutional sentiment increased to 1.26 in 2016 Q2. Its up 0.32, from 0.94 in 2016Q1. The ratio improved, as 25 funds sold all The Advisory Board Company shares owned while 53 reduced positions. 28 funds bought stakes while 45 increased positions. They now own 39.77 million shares or 7.82% less from 43.15 million shares in 2016Q1.

Invesco Limited holds 0% or 15,027 shares in its portfolio. Moreover, Sentinel Asset Mgmt has 0.28% invested in The Advisory Board Company (NASDAQ:ABCO) for 333,977 shares. Wells Fargo & Mn last reported 104,874 shares in the company. Marshall Wace Limited Liability Partnership accumulated 0.02% or 58,347 shares. Moreover, Paloma Ptnrs Mngmt has 0% invested in The Advisory Board Company (NASDAQ:ABCO) for 7,317 shares. Carroll Finance has 160 shares for 0% of their US portfolio. Paradigm Asset Management Llc holds 0% or 3,100 shares in its portfolio. The Texas-based Dimensional Fund Lp has invested 0.02% in The Advisory Board Company (NASDAQ:ABCO). Service Automobile Association owns 33,200 shares or 0% of their US portfolio. Ubs Asset Management Americas, a Illinois-based fund reported 20,899 shares. Tompkins Corp has invested 0.01% of its portfolio in The Advisory Board Company (NASDAQ:ABCO). Art Advsr Limited Liability Com accumulated 56,871 shares or 0.1% of the stock. Rail last reported 1% of its portfolio in the stock. Redmond Asset Ltd Liability Corp holds 0.36% or 20,361 shares in its portfolio. Federated Inc Pa has invested 0% of its portfolio in The Advisory Board Company (NASDAQ:ABCO).

Insider Transactions: Since May 31, 2016, the stock had 1 insider purchase, and 14 selling transactions for $1.36 million net activity. The insider KINDICK KELT bought 5,000 shares worth $164,050. 1,500 shares were sold by Miller Cormac F, worth $64,560. $68,520 worth of The Advisory Board Company (NASDAQ:ABCO) was sold by VAN HOOSE MARY. 5,500 shares with value of $236,995 were sold by Musslewhite Robert W on Monday, September 12. $103,224 worth of shares were sold by Kirshbaum Michael T on Tuesday, September 20. Farber Evan R had sold 2,924 shares worth $119,738. GRUA PETER J sold $103,600 worth of stock.

About 66,154 shares traded hands. The Advisory Board Company (NASDAQ:ABCO) has risen 17.34% since April 21, 2016 and is uptrending. It has outperformed by 12.01% the S&P500.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The company has a market cap of $1.48 billion. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle, clinical activities and supply chain. It currently has negative earnings. The Company’s higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations.

According to Zacks Investment Research, “The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.”

Analysts await The Advisory Board Company (NASDAQ:ABCO) to report earnings on February, 28. They expect $0.47 EPS, up 34.29% or $0.12 from last year’s $0.35 per share. ABCO’s profit will be $18.88 million for 19.60 P/E if the $0.47 EPS becomes a reality. After $0.15 actual EPS reported by The Advisory Board Company for the previous quarter, Wall Street now forecasts 213.33% EPS growth.

More notable recent The Advisory Board Company (NASDAQ:ABCO) news were published by: Prnewswire.com which released: “The Advisory Board Company to Participate in the Piper Jaffray Healthcare ..” on November 22, 2016, also Prnewswire.com with their article: “The Advisory Board Company Reports Third Quarter Results” published on November 01, 2016, Globenewswire.com published: “The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market ..” on November 17, 2016. More interesting news about The Advisory Board Company (NASDAQ:ABCO) were released by: Prnewswire.com and their article: “The Advisory Board Company to Report Third Quarter Financial Results After ..” published on October 11, 2016 as well as Prnewswire.com‘s news article titled: “The Advisory Board Company Reports Results For Quarter Ended June 30, 2016” with publication date: July 27, 2016.

ABCO Company Profile

The Advisory Board Company, incorporated on August 9, 2001, is a well-known provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle performance, clinical activities and supply chain management. The Company’s education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Firm offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>